Brief: EQL Chooses To Postpone The List Change To Nasdaq Stockholm

EQL Pharma AB

16/04/2021 08:46

April 16 (Reuters) - EQL Pharma AB  EQL.TE :
    * EQL CHOOSES TO POSTPONE THE LIST CHANGE TO NASDAQ
STOCKHOLM
    * GOAL THAT LIST CHANGE WILL BE CARRIED OUT AFTER SUMMER OF
2021
INSTEAD OF Q1 OF FINANCIAL YEAR 2021/22
    * DECISION TO POSTPONE LIST CHANGE IS DUE TO PRIORITIZATION
OF
ACQUISITION OF SEVEN PRODUCT LICENSES IN DENMARK
    * NEEDED TO MOVE RESOURCES FROM LISTING PROCESS TO
ACQUISITION.
    * POSTPONEMENT OF LIST CHANGE DOES NOT MEAN A STRATEGIC
CHANGE FOR
EQL PHARMA

Source text for Eikon:  ID:nWkr6zwc2N 
Further company coverage:  EQL.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))